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Association of a phosphatidylinositol-specific 3-kinase with a
human trans-Golgi network resident protein
D.M. Hickinson*, J.M. Lucocq†, M.C. Towler*, S. Clough*, J. James†, 
S.R. James*‡, C.P. Downes* and S. Ponnambalam*
The eukaryotic trans-Golgi network (TGN) is a key site
for the formation of transport vesicles destined for
different intracellular compartments [1]. A key marker
for the mammalian TGN is TGN38/46 [2]. This integral
membrane glycoprotein cycles between the TGN and
the cell surface and is implicated in recruitment of
cytosolic factors and regulation of at least one type of
vesicle formation at the mammalian TGN [2,3]. In this
study, we have identified a phosphatidylinositol
(PtdIns)-specific 3-kinase activity associated with the
human orthologue (TGN46), which is sensitive to lipid
kinase inhibitors. Treatment of HeLa cells with low
levels of these inhibitors reveals subtle morphological
changes in TGN46-positive compartments. Our findings
suggest a role for PtdIns 3-kinases and presumably for
the product, PtdIns 3-phosphate (PtdIns3P), in the
formation of secretory transport vesicles by
mechanisms conserved in yeast and mammals.
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Results and discussion
Increasing evidence implicates lipid kinases in membrane
traffic events [4,5]. The TGN46 glycoprotein is associated
with a specific set of cytoplasmic polypeptides [3].
TGN46 imunoprecipitates were assayed for kinase activity
on different lipid substrates (Figure 1a). TGN46 com-
plexes were found to contain a unique lipid kinase activity
that phosphorylates PtdIns (Figure 1a, lanes 1,2). In con-
trast, phosphorylation of PtdIns 4-phosphate (PtdIns4P)
was barely detectable (Figure 1a, lanes 3,4). Phosphoryla-
tion of phosphatidylinositol bisphosphate (PtdInsP2) was
not detected (Figure 1a, lanes 5,6). No significant lipid
kinase activity specific for the PtdIns substrate was
detected in cell extracts precipitated using protein
A–Seppharose beads only as controls (Figure 1a, lanes 7,8).
Affinity-purified sheep anti-TGN46 polyclonal antibodies
also immunoprecipitate a similar lipid kinase activity from
cell lysates (data not shown). Importantly, a similar,
TGN46-associated PtdIns-specific kinase activity was
detected in HeLa cells (data not shown). These data
further support the specific association of the lipid kinase
activity with the TGN46 protein complex.
The 32P-labelled product was deacylated and compared
with [3H]glycerophosphoinositol 3-phosphate (GroPIns3P)
and [3H]glycerophosphoinositol 4-phosphate (GroPIns4P)
standards (Figure 1b). The [32P]GroPInsP had an identi-
cal retention time to that of [3H]GroPIns3P. Thus the 32P-
labelled product generated by the TGN46-associated
PtdIns kinase corresponds to PtdIns3P and hence the
TGN46-associated enzyme is a PtdIns 3-kinase.
Different lipid kinases appear to have different cofactor
requirements and sensitivity to inhibitors (reviewed in
[4–6]). TGN46 immunoprecipitates were assayed for
PtdIns 3-kinase activity in the presence of different
amounts of PtdIns substrate, ATP, divalent cations and
potential inhibitors and activators. The TGN46-associated
lipid kinase has a Km of 205 µM for PtdIns; the Km for
ATP is approximately 70 µM. The kinase has an
absolute requirement for Mg2+, which cannot be substi-
tuted for by either Ca2+ or Mn2+. The TGN46-associated
PtdIns 3-kinase was strongly inhibited by relatively low
levels of both wortmannin and LY294002; the IC50 values
are approximately 2.5 nM and 2.5 µM, respectively. Poten-
tial lipid kinase regulators such as the PtdIns transfer
protein (PITP) [7] and TGN38-associated small soluble
GTP-binding proteins [3] may regulate TGN46-associ-
ated PtdIns 3-kinase activity. However, neither PITP nor
the non-hydrolysable GTP analogue GTPγS significantly
affected enzyme activity (data not shown). Pretreatment
of cells with compounds that affect TGN46 localisation,
such as brefeldin A or chloroquine, had little or no effect
on the levels of lipid kinase activity associated with the
TGN46 complex (data not shown). Transient overexpres-
sion of TGN46 in HeLa cells [8] does not increase levels
of PtdIns 3-kinase activity associated with the complex
(data not shown). In fact, increased levels of TGN46
reduced the levels of kinase activity detected in immuno-
precipitates by 20–40%. 
Rat TGN38 is associated with a cytoplasmic complex that
includes a 62 kDa phosphoprotein [3]. TGN46 complexes
from human U937 cells were immunoprecipitated from
35S-labelled detergent lysates and analysed by
SDS–PAGE and autoradiography (Figure 2b). Comparison
of control immunoprecipitates using rabbit pre-immune
serum (Figure 2b, lane 1) and anti-TGN46 polyclonal
antibodies reveals a discrete set of polypeptides associated
with the TGN46 complex; this includes the TGN46 glyco-
protein, a 62 kDa polypeptide (arrow in Figure 2b, lane 2)
and high-molecular-weight polypeptides at around
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Identification of a PtdIns 3-kinase activity associated with TGN46. 
(a) Different lipid substrates were incubated with TGN46
immunoprecipitates (lanes 1–6) from U937 cells or cell extracts and
protein A–Sepharose beads only (lanes 7,8), followed by thin-layer
chromatography analysis. Lipid substrates tested were PtdIns (lanes
1,2,7,8), PtdIns4P (lanes 3,4) or PtdInsP2 (lanes 5,6). Arrows mark the
positions corresponding to the different lipid standards. (b) HPLC
analysis of phosphorylated PtdIns product. HPLC profiles of 32P-
phosphorylated PtdIns product generated by the TGN46-associated
kinase and 3H-labelled standards for GroPIns3P and GroPIns4P.
Samples were chromatographed on a Partisphere 5 SAX column using
a linear gradient from 0–150 mM NH4H2PO4 pH 3.8 (1 ml min–1).
Fractions were collected at 20 sec intervals (fraction no., x-axis) and
counted in a scintillation counter (d.p.m., y-axis).
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Biochemical properties of TGN46-associated polypeptides. 
(a) Wortmannin and LY294002 inhibit TGN46-associated PtdIns 
3-kinase activity. Immunoprecipitates were assayed for the production
of PtdIns3P in the presence of different concentrations of wortmannin
or LY294002. The relative percentage of enzyme activity detected was
plotted against a log scale of concentrations of wortmannin or
LY294002. Each point on the graph is a mean of two duplicate
experiments. (b) 35S-labelled TGN46 complexes were
immunoprecipitated from U937 cells, fractionated on 10%
SDS–PAGE gels, dried, and analysed by autoradiography. 
(c) Immunoprecipitates bound to control protein G–Sepharose beads
(lane 1) or affinity-purified sheep anti-TGN46 antibodies bound to
protein G–Sepharose (lanes 2,3) were treated with [3H]wortmannin in
the absence (lanes 1,2) or presence (lane 3) of 100-fold excess of
cold wortmannin, fractionated on 8% SDS–PAGE gels and analysed
by autoradiography.
200–250 kDa (Figure 2b, lane 2). Similar results were
obtained from immunoprecipitations using affinity-puri-
fied sheep anti-TGN46 polyclonal antibodies (data not
shown). To identify wortmannin-sensitive catalytic sub-
units in the TGN46 complex, immunoprecipitates from
U937 cells were treated with 3[H]wortmannin (Figure 2c)
in the absence (lane 2) or presence (lane 3) of excess cold
wortmannin. No labelled polypeptides are visible in the
control immunoprecipitation (lane 1). However, a tritium-
labelled, high-molecular-weight polypeptide of approxi-
mately 250 kDa is visible upon treatment of the
immunoprecipitated TGN46 complex with [3H]wortman-
nin (Figure 2c, lane 2). 
HeLa cells treated with either wortmannin or LY294002
were analysed using light fluorescence microscopy; we did
not detect any significant overall effects on TGN46 local-
ization, in agreement with previous studies [9,10].
However, treatment with wortmannin or LY294002 did
cause accumulation of the transferrin receptor in endo-
somes, again in agreement with previous studies [10] (data
not shown). To look for effects at the ultrastructural level,
HeLa cells treated with 100 nM wortmannin were
processed for immuno-gold localisation of TGN46 on
ultrathin cryosections. In untreated controls, TGN46
is localised over a compact accumulation of tubulo-
vesicular profiles close to the Golgi stack (Figure 3a); this
compartment appears to be a mixture of tubules, vesicles
and cisternal membranes [11,12]. Upon treatment with
wortmannin (Figure 3c) or LY294002 (Figure 3b),
TGN46-positive structures tended to appear more dilated
and electron lucent (Figure 3b,c, arrowheads). 
TGN46-labelled profiles were further analysed by mea-
suring the diameter of both electron-dense and electron-
lucent structures (Figure 3d). In untreated controls, the
TGN46-labelled profiles generally ranged in size
between 50 and 150 nm in diameter (mean 70 nm; coeffi-
cient of error = 12%, n = 20). To further examine wort-
mannin effects on Golgi structure under these conditions
we also processed cells for conventional epoxy resin thin-
section analysis. Although electron-lucent profiles close
to the Golgi stack were detected in wortmannin-treated
cells, the effect was less marked than in cryosections
(results not shown).
The effects of wortmannin treatment were not observed
in every Golgi apparatus profile, but quantitation
showed a marked increase in the fraction of the
TGN46 labelling over electron-lucent structure profiles
from 27% (coefficient of error = 29%, n = 20) in
controls to 43% (coefficient of error = 26%, n = 21) upon
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Effects of wortmannin and LY294002 on the TGN46-labelled
compartment. Thin cryosections of control HeLa cells (a) or cells
treated with 50 µM LY294002 (b) or 100 nM wortmannin (c) were
labelled with rabbit polyclonal antibodies to TGN46 followed by
protein A–6 nm gold conjugates. Arrowheads in (b) and (c) point to
swollen electron-lucent structures labelled for TGN46 on the trans
side of the Golgi stack. The trans-Golgi network , asterisk in (a), and
the Golgi stack, G in (a–c), are labelled. Scale base in (c) = 1 µm. 
(d) A representative number of TGN46-labelled profiles from untreated
(control) and wortmannin (WT)-treated HeLa cells were analysed and
the diameter of each profile is represented. The mean profile size in
each experiment is indicated by the horizontal bar for each set of
values (see text).
wortmannin treatment. These swollen structures may be
derived from endosomal membranes or correspond to an
expansion of the TGN46-positive compartment in the
TGN. As these inhibitors affect several lipid kinases
[4–6], we cannot be certain that these effects are due to
the TGN46-associated enzyme. An alternative is that
PtdIns 3-kinase inhibition dramatically increases com-
partment volume by inhibition or activation of trans-
porters such as proton pumps. 
Increasing evidence suggests that PtdIns-specific 3-
kinases regulate membrane traffic events in the endocytic
pathway and from the TGN to distal compartments in
eukaryotes [4,6]. An important example is the Saccha-
romyces cerevisiae VPS34 gene product, which regulates
transport of carboxypeptidase Y from the Golgi apparatus
to the yeast vacuole [4]; the TGN46-associated PtdIns 3-
kinase may be involved in a similar step in membrane
traffic from the TGN to a distal compartment. A variety
of PtdIns-specific 3-kinases have been cloned from
eukaryotes and encode polypeptides ranging from
100 kDa–190 kDa (reviewed in [6]). Vps34 is a 100 kDa
polypeptide with PtdIns 3-kinase activity that is inhibited
only by relatively high micromolar concentrations of wort-
mannin [4]. However, in contrast to yeast Vps34, most of
the other mammalian PtdIns 3-kinases are sensitive to
low nanomolar concentrations of wortmannin. We have
identified a [3H]wortmannin-labelled polypeptide of
approximately 250 kDa in the TGN46 complex; this is
likely to account for the PtdIns 3-kinase activity associ-
ated with such complexes and is a candidate for the wort-
mannin and LY294002 target in vivo. Once sequences of
this polypeptide are obtained, it will be possible to deter-
mine whether it is a new or a previously identified
member of the PtdIns 3-kinase family. Preliminary work
by Howell and co-workers [13] suggests that a lipid
kinase activity is also associated with the rat orthologue,
TGN38. Cloning of the TGN46-associated PtdIns 3-
kinase enzyme described in this study, combined with
biochemical and cell biological investigations, will
provide new insights into the molecular principles gov-
erning such membrane dynamics.
Materials and methods
Immunoprecipitations, lipid kinase assays and electron
microscopy
TGN46 complexes were immunoprecipitated from U937 or HeLa cell
lysates as previously described [3] using rabbit anti-TGN46 [11] or
affinity-purified sheep anti-TGN46 (M.T. and S.P., unpublished obser-
vations) polyclonal antibodies. Lipid kinase assays were carried out as
previously described [14] and all experiments were carried out in dupli-
cate. Control immunoprecipitations using an equivalent amount of pre-
immune serum also showed less than 0.5% kinase activity (relative to
TGN46 immunoprecipitates) using PtdIns as a substrate. Deacylation
of lipids and subsequent analysis of the products were carried out
using base catalysis and HPLC [15]. Cells were treated for 2 h with
either of the lipid kinase inhibitors and processed for immuno-electron
microscopy as previously described [11,12].
Supplementary material
Further details of methodology and a table showing the biochemical
properties of the TGN46-associated PtdIns 3-kinase are published
with this paper on the internet.
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